serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.662 Movement Disorders .
C10.228.758 Ocular Motility Disorders .
C10.292 Cranial Nerve Diseases .
C10.292.562 Ocular Motility Disorders .
C11 Eye Diseases .
C11.590 Ocular Motility Disorders .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.954 Therapeutic Uses .
D27.505.954.427 Central Nervous System Agents .
D27.505.954.427.090 Anti-Dyskinesia Agents .
F03 Mental Disorders .
F03.625 Neurodevelopmental Disorders .
F03.625.984 Stereotypic Movement Disorder .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Movement Disorders .
Movement Disorder Syndromes .
Dyskinesia Syndrome .
Movement Disorder .
Movement Disorder Syndrome .
Etat Marbre .
Status Marmoratus .
Dyskinesia Syndromes .
Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. .
1.00
16613597
 
Ocular Motility Disorders .
Brown's Tendon Sheath Syndrome .
Convergence Excess .
Cyclophoria .
Deficiency, Smooth Pursuit .
Eye Motility Disorders .
Parinaud's Syndrome .
Paroxysmal Ocular Dyskinesia .
Pseudoophthalmoplegia .
Spasm of Conjugate Gaze .
Syndrome, Brown's Tendon Sheath .
Tendon Sheath Syndrome of Brown .
Conjugate Gaze Spasm .
Conjugate Gaze Spasms .
Convergence Excesses .
Convergence Insufficiencies .
Cyclophorias .
Deficiencies, Smooth Pursuit .
Deviation, Skew .
Deviations, Skew .
Dyskinesia, Paroxysmal Ocular .
Dyskinesias, Paroxysmal Ocular .
Excess, Convergence .
Eye Motility Disorder .
Eye Movement Disorder .
Gaze Spasms, Conjugate .
Insufficiencies, Convergence .
Insufficiency, Convergence .
Internuclear Ophthalmoplegias .
Ocular Dyskinesia, Paroxysmal .
Ocular Dyskinesias, Paroxysmal .
Ocular Motility Disorder .
Ophthalmoplegia, Internuclear .
Ophthalmoplegias, Internuclear .
Parinauds Syndrome .
Paroxysmal Ocular Dyskinesias .
Pseudoophthalmoplegias .
Pursuit Deficiencies, Smooth .
Pursuit Deficiency, Smooth .
Skew Deviations .
Smooth Pursuit Deficiencies .
Syndrome, Parinaud .
Syndrome, Parinaud's .
Ocular Torticollis .
Eye Movement Disorders .
Opsoclonus .
Brown Tendon Sheath Syndrome .
Convergence Insufficiency .
Internuclear Ophthalmoplegia .
Parinaud Syndrome .
Skew Deviation .
Smooth Pursuit Deficiency .
EYE MOTILITY DISORDERS .
Disorders that feature impairment of eye movements as a primary manifestation of disease. These conditions may be divided into infranuclear, nuclear, and supranuclear disorders. Diseases of the eye muscles or oculomotor cranial nerves (III, IV, and VI) are considered infranuclear. Nuclear disorders are caused by disease of the oculomotor, trochlear, or abducens nuclei in the BRAIN STEM. Supranuclear disorders are produced by dysfunction of higher order sensory and motor systems that control eye movements, including neural networks in the CEREBRAL CORTEX; BASAL GANGLIA; CEREBELLUM; and BRAIN STEM. Ocular torticollis refers to a head tilt that is caused by an ocular misalignment. Opsoclonus refers to rapid, conjugate oscillations of the eyes in multiple directions, which may occur as a parainfectious or paraneoplastic condition (e.g., OPSOCLONUS-MYOCLONUS SYNDROME). (Adams et al., Principles of Neurology, 6th ed, p240) .
0.86
873205
 
Anti-Dyskinesia Agents .
Agents, Anti-Dyskinesia .
Agents, Movement Disorder .
Anti Dyskinesia Agents .
Disorder Agents, Movement .
Movement Disorder Agents .
Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias. .
0.85
281173
 
Stereotypic Movement Disorder .
Stereotypic Movement Disorders .
Body Rocking .
Head Banging .
Movement Disorder, Stereotypic .
Offensa Capitis .
Motor behavior that is repetitive, often seemingly driven, and nonfunctional. This behavior markedly interferes with normal activities or results in severe bodily self-injury. The behavior is not due to the direct physiological effects of a substance or a general medical condition. (DSM-IV, 1994) .
0.76
16432